Alphacetylmethadol

Not to be confused with acetylmethadol.[1]
Alphacetylmethadol
Systematic (IUPAC) name
[(3R*,6R*)-6-dimethylamino-4,4-di(phenyl)heptan-3-yl] acetate
Clinical data
Identifiers
1553-31-7
None
ChEMBL CHEMBL2107793
Chemical data
Formula C23H31NO2
353.5034 g/mol

Alphacetylmethadol (INN), or α-acetylmethadol (AAM), is a synthetic opioid analgesic.[2] Its levorotary enantiomer, levacetylmethadol, is an FDA-approved treatment for opioid addiction.[2] Alphacetylmethadol is very similar in structure to methadone, a widely-prescribed treatment for opioid addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act (presumably due to the fact that it was never marketed in the US, as is the case with other common opiate/opioid medications such as diacetylmorphine and alphaprodine), with an ACSCN of 9603 and a 2013 annual manufacturing quota of 2 grammes.[3]

See also

References

  1. ↑ Richard Lawrence Miller (30 December 2002). The Encyclopedia of Addictive Drugs. Greenwood Publishing Group. p. 222. ISBN 978-0-313-31807-8. Retrieved 15 May 2012.
  2. ↑ 2.0 2.1 Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.
  3. ↑ 21 U.S.C. § 812(b)(1)